<SEC-DOCUMENT>0001493152-22-012630.txt : 20220510
<SEC-HEADER>0001493152-22-012630.hdr.sgml : 20220510
<ACCEPTANCE-DATETIME>20220510092203
ACCESSION NUMBER:		0001493152-22-012630
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220509
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220510
DATE AS OF CHANGE:		20220510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		22907642

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:PRPH="http://prophaselabs.com/20220509">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_PRPH_prophaselabs.com_20220509 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220509_20220509 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000868278 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityCentralIndexKey">0000868278</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prph-20220509.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-05-09to2022-05-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-09</xbrli:startDate>
        <xbrli:endDate>2022-05-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20220509__20220509_zflOCMlagZLe"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_90D_edei--DocumentPeriodEndDate_c20220509__20220509_zIhWRdUtPEk6"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 9, 2022</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20220509__20220509_z6xxHVeb2lYk"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityRegistrantName">PROPHASE
LABS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Company as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20220509__20220509_zpkXjwuSgbi2"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20220509__20220509_zG7uvkjwty2d"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityFileNumber">000-21617</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20220509__20220509_zE1L8ikiqln1"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityTaxIdentificationNumber">23-2577138</ix:nonNumeric></span>
    </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20220509__20220509_zkEcprmpa7mi"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressAddressLine1">711
    Stewart Avenue</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20220509__20220509_zNAzZpFtvAq2"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_906_edei--EntityAddressAddressLine3_c20220509__20220509_zlK1lfTT8NM5"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressAddressLine3">G</ix:nonNumeric></span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20220509__20220509_zUzVAPhy4EG4"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressCityOrTown">arden
    City</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20220509__20220509_zTCD00LqJOc8"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressPostalZipCode_c20220509__20220509_zFgfFHNVk3j1"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressPostalZipCode">11530</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_90D_edei--CityAreaCode_c20220509__20220509_zizr42fDLa78"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:CityAreaCode">(215)</ix:nonNumeric></span> <span id="xdx_902_edei--LocalPhoneNumber_c20220509__20220509_zKoNF3KXAw4k"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:LocalPhoneNumber">345-0919</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any
of the following provisions (<i>see</i> General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20220509__20220509_zApVFosHSnUj"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SolicitingMaterial_c20220509__20220509_zGaoQ2rr7dXa"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementTenderOffer_c20220509__20220509_zvHNnX44y4Zi"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20220509__20220509_z0oKd3PvtIze"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Registered Pursuant to Section 12(b) of the Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Each Exchange on Which Registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20220509__20220509_zTIGFgpJ3soe"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:Security12bTitle">Common
    Stock, par value $0.0005</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20220509__20220509_zvLKMSfEf5b7"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:TradingSymbol">PRPH</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SecurityExchangeName_c20220509__20220509_zlECekcHUOa5"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20220509__20220509_z4mAaGVGJlwf"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2022, ProPhase Labs, Inc. (the &#8220;Company&#8221;) announced that it will appoint Bill White, age 61, as Chief Financial Officer
of the Company, effective May 23, 2022 (the &#8220;Effective Date&#8221;), replacing Monica Brady, who is currently serving as Chief
Financial Officer of the Company. Ms. Brady will remain with the Company and continue to serve as the Company&#8217;s Chief Accounting
Officer, and Chief Financial Officer of the Company&#8217;s wholly-owned subsidiary, ProPhase Diagnostics, Inc., as of the Effective
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
White has served as Chief Financial Officer, Treasurer and Secretary of Intellicheck, Inc. (Nasdaq: IDN), an identity company that delivers
on-demand digital identity validation solutions for KYC, fraud, and age verification needs, since April 2012, and Chief Operating Officer
since March 2020. Mr. White has more than 30 years of experience in financial management, operations and business development. Prior
to joining Intellicheck, he served 11 years as the Chief Financial Officer, Secretary and Treasurer of FocusMicro, Inc. (&#8220;FM&#8221;).
As co-founder of FM, Mr. White played an integral role in growing the business from the company&#8217;s inception to over $36 million
in annual revenue in a five-year period. Mr. White has broad domestic and international experience including managing rapid and significant
growth, import/export, implementing tough cost management initiatives, exploiting new growth opportunities, merger and acquisitions,
strategic planning, resource allocation, tax compliance and organization development. Prior to co-founding FM, he served 15 years in
various financial leadership positions in the government sector. Mr. White started his career in Public Accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his appointment as Chief Financial Officer, the Company entered into an employment agreement with Mr. White on May 9,
2022 (the &#8220;Employment Agreement&#8221;), which will become effective on the Effective Date, pursuant to which Mr.
White will receive an annual base salary of $350,000 (as may be adjusted from time to time). Mr. White will also be entitled to receive
a minimum annual bonus for calendar year 2022 in a gross amount equal to $50,000.00, provided that he is actively employed by the Company
and in good standing, without having received from or tendered to the Company notice of an anticipated termination (for any reason).
Future discretionary annual bonuses will be determined in the sole discretion of the compensation committee of the Company&#8217;s board
of directors (the &#8220;Compensation Committee&#8221;). Mr. White will also be eligible to participate in any and all benefit plans
of the Company that are made generally available to similarly-situated employees of the Company. The Employment Agreement contains customary
non-competition, non-solicitation and confidentiality clauses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an inducement to his employment as Chief Financial Officer of the Company, the Compensation Committee also granted Mr. White a stock
option (the &#8220;Option Award&#8221;) to purchase up to 400,000 shares of the Company&#8217;s common stock. This award was made in
accordance with the employment inducement award exemption provided by Nasdaq Rule 5635(c)(4) and was therefore not awarded under the
Company&#8217;s stockholder approved equity plan. The option award will vest over a four year period, with 12.5% vesting every six months
following the date his employment commences, and contingent upon the commencement of his employment and continued service through each
vesting date. The options have an exercise price of $6.74 per share, the closing price of the Company&#8217;s common stock on May 9,
2022, and will be exercisable for a period of seven years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Employment Agreement, if Mr. White&#8217;s employment is terminated by the Company without Cause (as defined in the
Employment Agreement), other than as a result of his death or disability, Mr. White will, in addition to any entitlements under the Option
Award, be entitled to receive: (i) any annual salary then in effect, earned but unpaid as of the termination date (&#8220;Earned Salary&#8221;),
and (ii) subject to the Company&#8217;s receipt from Mr. White of a release of any claims against the Company, an amount equal to (a)
six months of his then current annual salary if his employment is terminated on or prior to the one-year anniversary of the Effective
Date or (b) an amount equal to 12 months of his then current salary if his employment is terminated following the one-year anniversary
of the Effective Date. If Mr. White&#8217;s employment is terminated by the Company with Cause, by Mr. White for any reason at any time,
as a result of Mr. White&#8217;s death, or for any reason other than by the Company without Cause, Mr. White will receive only the Earned
Salary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
are no family relationships between Mr. White and any of the officers or directors of the Company, and there are no related party transactions
with Mr. White that are reportable under Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 10, 2022, the Company issued a press release announcing the appointment of Mr. White as the Company&#8217;s new Chief Financial Officer.
A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 73px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Employment Agreement, dated as of May 9, 2022, by and between ProPhase Labs, Inc. and Bill White</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Inducement Option Award Agreement, dated May 9, 2022, by and between ProPhase Labs, Inc. and Bill White.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated May 10, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ProPhase
    Labs, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Monica Brady</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica
    Brady</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 10, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZF20CLuzSokWsUoqI22CnEmwzZRJ/eiRvaWwRh4FheO97T4hY5LQxLTKcV1UBR+z6VnuEChtktBcMjmy7SyHcCq/GedbWj+8PzCgwGJjFTCodhNH6MA7rFJLFPFnOlQIpU6mg3Ivoq2dkG1Oj9Ua3oG0NJVPPBr3mYUo46hdZ6oax6oTsDNkU5CyZ5DeoJOQd6KGfxDcHRZGJKB4nEjnTvf/W3J2nDtYtdqHLTeh/ow8WCklG -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Employment Agreement (this &ldquo;Agreement&rdquo;) is effective as of May 23, 2022 (the &ldquo;Effective Date&rdquo;), and is entered
into by and between ProPhase Labs, Inc. (the &ldquo;Company&rdquo;), and Bill White (&ldquo;Employee&rdquo;) (collectively with the Company,
the &ldquo;Parties&rdquo;; each of the Parties referred to individually as a &ldquo;Party&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company desires to employ Employee, in accordance with the terms and conditions set forth below; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Employee desires to be employed by the Company, in accordance with the terms and conditions set forth below;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the promises and mutual covenants and agreements set forth in this Agreement, the Parties hereby agree
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <B><U>EMPLOYMENT</U></B>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Title</U></B>.
    The Company hereby agrees to employ Employee, and Employee hereby accepts such employment, as Chief Financial Officer of the Company,
    reporting to the Company&rsquo;s Chief Executive Officer.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>At
    Will Relationship</U></B>. Employee&rsquo;s employment with the Company shall commence as of the Effective Date. Employee&rsquo;s
    employment shall be considered &ldquo;at will&rdquo; in nature and, accordingly, either the Company or Employee may terminate this
    Agreement and Employee&rsquo;s employment at any time and for any reason, with or without cause or prior notice. Nothing in this
    Agreement, including but not limited to Section 3 hereof, shall be construed as, or shall interfere with, abridge, limit, modify,
    or amend the &ldquo;at will&rdquo; nature of Employee&rsquo;s employment with Company. Except as set forth in Section 3 of this Agreement,
    upon Employee&rsquo;s separation from employment with the Company (for any reason), all compensation and benefits payable or provided
    to Employee shall, except as required by applicable law, terminate as of the effective date of Employee&rsquo;s termination (the
    &ldquo;Termination Date&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Duties
    and Responsibilities</U></B>. During Employee&rsquo;s employment with the Company, Employee shall at all times: (i) comply with the
    terms and conditions set forth in this Agreement; (ii) perform and carry out such responsibilities, duties, and authorities as the
    Company may direct, designate, request of, or assign to Employee from time to time, which shall include, but not necessarily be limited
    to, such responsibilities, duties, and authorities that are typically performed by and assigned to employees in similar positions
    within similar companies; (iii) perform the duties and carry out the responsibilities assigned to him by the Company to the best
    of his ability, in a trustworthy, business-like, and efficient manner for the purpose of advancing the business and interests of
    the Company; (iv) devote sufficient time, attention, effort, and skill to his position with and the business of the Company; (v)
    comply with and abide by the Company&rsquo;s policies, practices, and procedures (as may be amended or otherwise modified from time
    to time by the Company); and (vi) comply with all laws, rules, regulations, and licensing requirements of, or that may be applicable
    to, his employment with the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that any term(s) of this Agreement conflicts with a term(s) of any employee handbook, policy, practice, or procedure adopted
or maintained, at any time, by the Company, the term(s) of this Agreement shall control and supersede such conflicting term(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
    Conflicts</U></B>. Employee represents and warrants that he is not bound by or subject to any written or oral agreement, pact, covenant,
    or understanding with any previous employer, or any other party, that would limit, abridge, restrict, or interfere with, in any way,
    his ability to perform his duties and obligations hereunder. Employee further represents and warrants that the performance of his
    duties and obligations hereunder shall not violate any written or oral agreement, pact, covenant, or understanding by and between
    him and any previous employer, or any other party. Employee further represents and warrants that he will not use any trade secret,
    or confidential or proprietary information, of any of his previous employers, or that was obtained, learned, or procured during any
    period of employment prior to his employment with the Company, in connection with his employment with the Company or in the performance
    of his duties and obligations hereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <B><U>COMPENSATION
AND BENEFITS</U></B>. Subject to the terms and conditions of Sections 1(b) and 3 of this Agreement and Employee&rsquo;s continued employment
with the Company, and in consideration for the services to be provided hereunder by Employee, the Company hereby agrees to pay or otherwise
provide Employee with the following compensation and benefits during his employment with the Company:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annual
    Salary</U></B>. The Company shall pay Employee a base salary equal to $350,000.00 per year (as it may be adjusted from time to time,
    the &ldquo;Annual Salary&rdquo;), less applicable taxes, withholdings, and deductions, and any other deductions that may be authorized
    by Employee, from time to time, in accordance with applicable federal, state, and/or local law. The Annual Salary shall be payable
    in accordance with the Company&rsquo;s standard payroll practices and procedures, as in effect from time to time. Employee acknowledges
    and understands that his position of employment with the Company is considered &ldquo;exempt,&rdquo; as that term is defined under
    the Fair Labor Standards Act and applicable state or local law. As an exempt employee, Employee is not eligible to receive overtime
    pay.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Discretionary
    Bonus</U></B>. Following the end of each fiscal year of the Company, Employee shall be eligible to receive a discretionary bonus
    payment (any bonus awarded hereunder shall hereinafter be referred to as an &ldquo;Annual Bonus&rdquo;). The specific amount, if
    any, of any Annual Bonus shall be determined in the sole discretion of the Company&rsquo;s Compensation Committee. Any Annual Bonus
    will be paid in accordance with the Company&rsquo;s bonus payment practices in effect from time to time for similarly-situated employees
    of the Company, including tax withholdings. In order to earn, accrue, and receive any Annual Bonus, Employee must be actively employed
    by the Company in good standing, without having received from or tendered to the Company notice of an anticipated termination (for
    any reason), at the time that such bonus is to be paid to Employee. Payment of a bonus for any year will not give rise to an entitlement
    or expectation of a bonus for any other year.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, for calendar year 2022, Employee shall receive a minimum Annual Bonus in a gross amount equal to $50,000.00, provided
that he is actively employed by the Company in good standing, without having received from or tendered to the Company notice of an anticipated
termination (for any reason), at the time that the Annual Bonus for calendar year 2022 is to be paid to Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Benefit
    Plans</U></B>. Employee shall be entitled to participate in any and all medical insurance, group health, disability insurance, life
    insurance, incentive, savings, retirement, and other benefit plans, if any, which are made generally available to similarly-situated
    employees of the Company (and subject to eligibility requirements, enrollment criteria, and other terms and conditions of such plans),
    and which the Company, in its sole discretion, may at any time amend, modify, or terminate, subject to the terms and conditions of
    such plans and applicable federal, state, or local law.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Equity
    Award</U></B>. Effective upon the signing of this Agreement by the parties hereto (the &ldquo;<B>Signing Date</B>&rdquo;), the Employee
    shall be granted a nonstatutory stock option to purchase 400,000 shares of the Company&rsquo;s Common Stock with an exercise price
    per share equal to the closing price of the Company&rsquo;s common stock on the Nasdaq Capital Market on the Signing Date, pursuant
    to the form of grant agreement attached to this Agreement as an Exhibit (the &ldquo;Grant Agreement&rdquo;). The stock option is
    to be granted as an inducement grant pursuant to the inducement grant exception under Nasdaq Rule 5635(c)(4), and on terms consistent
    with those provided under the ProPhase Labs Inc. 2022 Equity Compensation Plan, as amended and restated, including without limitation
    the adjustment provisions thereof which provide for adjustments upon share dividends, special dividends and distributions, and with
    vesting over a four-year period, pursuant to which 12.5% (representing an option for 50,000 shares) will vest every six months, subject
    to the Employee remaining employed with the Company on each vesting date. Notwithstanding anything herein to the contrary, in the
    event that Employee does not commence employment with the Company on the Effective Date (for any reason), the Parties acknowledge
    and agree that this Agreement, including but not limited to this Section 2(d), shall be null, void, and unenforceable, that no Party
    shall have any rights or entitlements under this Agreement, and, accordingly, that any grant pursuant to this Section (d) shall be
    deemed automatically cancelled.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Vacation
    and Sick Leave</U></B>. Employee shall be entitled to three weeks&rsquo; vacation per year (prorated for partial years of employment),
    and sick leave, in accordance with the Company&rsquo;s respective vacation and sick leave policies, as in effect from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Expenses</U></B>.
    Employee shall be entitled to reimbursement for all reasonable expenses that he incurs in connection with the performance of his
    duties and obligations hereunder. Upon presentment by Employee of appropriate and sufficient documentation, as determined in the
    Company&rsquo;s sole discretion, the Company shall reimburse Employee for all such expenses in accordance with the Company&rsquo;s
    expense reimbursement policy, as in effect from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <B><U>EFFECT OF
TERMINATION</U></B>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definition
    of Cause</U></B>. For purposes of this Agreement, the term &ldquo;Cause&rdquo; shall mean: (a) any act or omission of Employee that,
    in connection with his employment with the Company, amounts to or constitutes a breach of a fiduciary duty, gross negligence, willful
    misconduct, or material misconduct, or that amounts to or constitutes fraud, embezzlement, or misappropriation; (b) Employee&rsquo;s
    breach of any term(s) of this Agreement; (c) Employee&rsquo;s violation of any policy(ies) established, adopted, or maintained by
    the Company; (d) any act or omission of Employee that, in the Company&rsquo;s sole discretion, is demonstrably and materially injurious
    to the Company; (e) any act or omission of Employee that causes the Company to suffer or endure public disgrace, disrepute, or economic
    harm; (f) Employee&rsquo;s misappropriation of corporate assets or corporate opportunities; (g) Employee&rsquo;s conviction of a
    felony, a crime involving financial dishonesty towards the Company, or a crime involving moral turpitude; or (h) Employee&rsquo;s
    failure to follow the reasonable directives of the Company or to perform the material responsibilities or duties of his position.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination
    by the Company Without Cause</U></B>. If Employee&rsquo;s employment is terminated by the Company without Cause (and expressly excluding
    any termination due to Employee&rsquo;s death or Disability), Employee shall, in addition to any entitlements under the Grant Agreement,
    receive only:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    Annual Salary earned but unpaid as of the Termination Date (the &ldquo;Earned Salary&rdquo;); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to Employee meeting the terms and conditions of Section 3(d) below, the Separation Payment, which shall be paid in substantially
    equal installments commencing with the first regular payroll of the Company following the effective date of the Release (as that
    term is defined below), and if at all, in any event no later than seventy (70) days after the Termination Date. For purposes of this
    Agreement, the term &ldquo;Separation Payment&rdquo; shall mean (i) an amount equal to six months of the then-current Annual Salary
    as of the Termination Date, in the event that Employee&rsquo;s employment is terminated on or prior to the one-year anniversary of
    the Effective Date; and (ii) an amount equal to 12 months of the then-current Annual Salary as of the Termination Date, in the event
    that Employee&rsquo;s employment is terminated following the one-year anniversary of the Effective Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination
    with Cause and All Other Terminations</U></B>. If Employee&rsquo;s employment is terminated by the Company with Cause at any time,
    by Employee for any reason at any time, due to Employee&rsquo;s death, or for any reason other than as specified in Sections 3(b)
    above at any time during Employee&rsquo;s employment with the Company, Employee shall receive only the Earned Salary.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Release
    of Claims Against the Company</U></B>. Notwithstanding the foregoing, no payment shall be made or benefit provided to Employee or
    Employee&rsquo;s estate, as applicable, pursuant to this Section 3 of the Agreement, other than the Earned Salary, unless Employee
    or a representative or agent of Employee&rsquo;s estate, as applicable, signs and, if applicable, does not revoke a general release
    of all claims against the Company, and any related, affiliated, or associated persons and/or entities as the Company may designate
    or determine in its sole discretion, in such form as the Company may reasonably require (the &ldquo;Release&rdquo;). The Release
    must be signed by Employee or Employee&rsquo;s estate, as applicable, and returned to the Company within the period designated by
    the Company, which shall not extend later than fifty (50) days after the Termination Date. Any payment to be made or benefit provided
    pursuant to this Section 3 of the Agreement shall be tendered in accordance with the schedule to be set forth in the Release.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <B><U>RESTRICTIVE
COVENANTS</U></B>. The Parties agree that the Company is engaged in a highly competitive industry and would suffer irreparable harm
and incur substantial damage if Employee were to enter into competition with the Company. Therefore, in order for the Company to
protect its legitimate business interests, Employee covenants and agrees as follows:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall not, at any time during his employment with the Company and for a period of six months thereafter, anywhere in the geographic
    areas in which Employee, at any time during his employment, provided services or had a material presence or influence on behalf of
    the Company, either directly or indirectly: (i) accept employment with or render services to (whether as an agent, servant, owner,
    partner, consultant, employee, independent contractor, representative, director, officer, or stockholder) any person or entity that
    is a business competitor of the Company, or has at any time during Employee&rsquo;s employment with the Company engaged or attempted
    to engage in business competition with the Company, in a position, capacity, or function that is similar, in title or substance,
    whether in whole or in part, to any position, capacity, or function that Employee held with or in which Employee served the Company;
    or (ii) invest in any person or entity that is a business competitor of the Company, or has at any time during Employee&rsquo;s employment
    with the Company engaged or attempted to engage in business competition with the Company, except that Employee may own up to one
    percent (1%) of any outstanding class of securities of any company registered under Section 12 of the Securities Exchange Act of
    1934, as amended;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall not, at any time during his employment with the Company and for a period of 12 months thereafter, for any reason, on his own
    behalf or on behalf of any other person or entity, by or through any means including but not limited to social media: (i) solicit,
    invite, induce, cause, or encourage to alter or terminate his, her, or its business relationship with the Company, any client, customer,
    supplier, vendor, licensee, licensor, or other person or entity that, at any time during Employee&rsquo;s employment with the Company,
    had a business relationship with the Company, or any person or entity whose business the Company was soliciting or attempting to
    solicit at the time of Employee&rsquo;s termination, (a) for whom Employee performed services or with whom Employee had contact during
    his employment with the Company, or whose business Employee was soliciting or attempting to solicit at the time of Employee&rsquo;s
    termination, and (b) with whom Employee did not have a business relationship prior to his employment with the Company; (ii) solicit,
    entice, attempt to solicit or entice, or accept business from any such client, customer, supplier, vendor, licensee, licensor, person,
    or entity; or (iii) interfere or attempt to interfere with any aspect of the business relationship between the Company and any such
    client, customer, supplier, vendor, licensee, licensor, person, or entity; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall not, at any time during his employment with the Company and for a period of 12 months thereafter, either directly or indirectly,
    on his own behalf or on behalf of any other person or entity, by or through any means including but not limited to social media:
    (i) solicit, invite, induce, cause, or encourage any director, officer, employee, agent, representative, consultant, or contractor
    of the Company to alter or terminate his, her, or its employment, relationship, or affiliation with the Company; (ii) interfere or
    attempt to interfere with any aspect of the relationship between the Company and any such director, officer, employee, agent, representative,
    consultant, or contractor; or (iii) engage, hire, or employ, or cause to be engaged, hired, or employed, in any capacity whatsoever,
    any such director, officer, employee, agent, representative, consultant, or contractor.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
represents, warrants, agrees, and understands that: (i) the covenants and agreements set forth in this Section 4 of the Agreement are
reasonable in their geographic scope, temporal duration, and the type and scope of activities they restrict; (ii) the Company&rsquo;s
agreement to employ Employee, and a portion of the compensation to be paid to Employee hereunder, are in consideration for such covenants
and Employee&rsquo;s continued compliance therewith, and constitute adequate and sufficient consideration for such covenants; (iii) Employee
shall not raise any issue of, nor contest or dispute, the reasonableness of the geographic scope, temporal duration, or content of such
covenants and agreements in any proceeding to enforce such covenants and agreements; (iv) the enforcement of any remedy under this Agreement
will not prevent Employee from earning a livelihood, because Employee&rsquo;s past work history and abilities are such that Employee
can reasonably expect to find work in other areas and lines of business; (v) the covenants and agreements set forth in this Section 4
of the Agreement are essential for the Company&rsquo;s reasonable protection, are designed to protect the Company&rsquo;s legitimate
business interests, and are necessary and implemented for legitimate business reasons; and (vi) in entering into this Agreement, the
Company has relied upon Employee&rsquo;s representation that he will comply in full with the covenants and agreements set forth in this
Section 4 of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Employee breaches Section 4(a), 4(b), or 4(c) above, then the period during which that section remains in effect shall be extended by
the length of time during which such breach continues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <B><U>CONFIDENTIALITY</U></B>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Confidential
    Information</U></B>. Employee acknowledges that during his employment with the Company, and by the nature of Employee&rsquo;s duties
    and obligations hereunder, Employee will come into close contact with confidential information of the Company and its subsidiaries,
    affiliates, and/or other related entities, as applicable, including but not limited to: trade secrets, know-how, Intellectual Property
    (as that term is defined below), business plans, client/customer lists, pricing, sales and marketing information, products, research,
    algorithms, market intelligence, services, technologies, concepts, methods, sources, methods of doing business, patterns, processes,
    compounds, formulae, programs, devices, tools, compilations of information, development, manufacturing, purchasing, engineering,
    computer programs (whether in source code or object code), theories, techniques, procedures, strategies, systems, designs, works
    of art, the identity of and any information concerning affiliates or customers, or potential customers, information received from
    others that the Company is obligated to treat as confidential or proprietary, and any other technical, operating, non-public financial,
    and other business information that has commercial value, whether relating to the Company, its business, potential business, or operations,
    or the business of any of the Company&rsquo;s affiliates, subsidiaries, related entities, clients, customers, suppliers, vendors,
    licensees, or licensors, that Employee may develop or of which Employee may acquire knowledge during his employment with the Company,
    or from his colleagues while working for the Company, whether prior to, during, or subsequent to his execution of this Agreement,
    and all other business affairs, methods, and information not readily available to the public (collectively, &ldquo;Confidential Information&rdquo;).
    Confidential Information does not include: (i) information that is or becomes publicly available without any direct or indirect act
    or omission on Employee&rsquo;s part; or (ii) information that is required to be disclosed pursuant to any applicable law, regulation,
    judicial or administrative order or decree, or request by other regulatory organization having authority pursuant to the law; provided,
    however, that, except as set forth in and subject to Section 5(b) of this Agreement, Employee shall first have given reasonable notice
    to the Company prior to making such disclosure.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
acknowledges and agrees that each and every part of the Company&rsquo;s Confidential Information: (a) has been developed by the Company
at significant effort and expense; (b) is sufficiently secret to derive economic value from not being generally known to other parties;
(c) is proprietary to and a trade secret of the Company and, as such, is a valuable, special, and unique asset of the Company; and (d)
constitutes a protectable business interest of the Company. Employee further acknowledges and agrees that any unauthorized use or disclosure
of any Confidential Information by Employee will cause irreparable harm and loss to the Company. Employee acknowledges and agrees that
the Company owns the Confidential Information. Employee agrees not to dispute, contest, or deny any such ownership rights either during
or after Employee&rsquo;s employment with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recognition of the foregoing, and except as set forth in and subject to Section 5(b) of this Agreement, Employee covenants and agrees
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    will use Confidential Information only in the performance of his duties and obligations hereunder for the Company. Employee will
    not use Confidential Information, directly or indirectly, at any time during or after his employment with the Company, for his personal
    benefit, for the benefit of any other person or entity, or in any manner adverse to the interests of the Company. Further, Employee
    will keep secret all Confidential Information and will not make use of, divulge, or otherwise disclose Confidential Information,
    directly or indirectly, to anyone outside of the Company, except with the Company&rsquo;s prior written consent;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    will take all necessary and reasonable steps to protect Confidential Information from being disclosed to anyone within the Company
    who does not have a need to know the information and to anyone outside of the Company, except with the Company&rsquo;s prior written
    consent;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall not at any time remove, copy, download, or transmit any information from the Company during the term of this Agreement, except
    for the benefit of the Company and in accordance with this Agreement and the Company&rsquo;s policies; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
    upon Employee&rsquo;s termination, and in any event no later than three (3) business days after Employee&rsquo;s employment with
    the Company ceases, Employee shall return to the Company any and all Confidential Information in his possession, custody, or control.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Duration
    of Covenant</U></B>. Employee acknowledges and agrees that his obligations under this Section 5 of the Agreement shall remain in
    effect forever.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, nothing in this Agreement shall be construed as, or shall interfere with, abridge, limit, restrain, or restrict Employee&rsquo;s
(or his attorney&rsquo;s) right, without prior authorization from or notification to the Company: (i) to communicate with any federal,
state, or local government agency charged with the enforcement and/or investigation of claims of discrimination, harassment, retaliation,
improper wage payments, or any other unlawful employment practices under federal, state, or local law, or to file a charge, claim, or
complaint with, or participate in or cooperate with any investigation or proceeding conducted by, any such agency; (ii) to report possible
violations of federal, state, or local law or regulation to any government agency or entity, including but not limited, to the extent
applicable, to the U.S. Department of Labor, the Department of Justice, the Securities and Exchange Commission (the &ldquo;SEC&rdquo;),
the Congress, and/or any agency Inspector General, or make other disclosures that are protected under the whistleblower provisions of
federal, state, or local law or regulation; or (iii) to communicate directly with, respond to any inquiry from, or provide testimony
before, to the extent applicable, the SEC, the Financial Industry Regulatory Authority, any other self-regulatory organization, or any
other federal, state, or local regulatory authority, regarding this Agreement or its underlying facts or circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a
trade secret that: (A) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or
to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint
or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Further, in the event that Employee files
a lawsuit for retaliation by the Company for reporting a suspected violation of law, Employee may disclose the trade secret to his attorney
and use the trade secret information in the court proceeding, if Employee: (A) files any document containing the trade secret under seal;
and (B) does not disclose the trade secret, except pursuant to court order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B><U>INJUNCTIVE RELIEF</U></B>. Employee agrees that it would be difficult to measure any damages caused to the Company which might
result from any breach by Employee of the covenants and agreements set forth in Sections 4 and 5 of this Agreement, and that in any event
money damages would be an inadequate remedy for any such breach. Accordingly, and notwithstanding any other provision of this Agreement,
Employee agrees that if Employee breaches, or the Company reasonably believes that Employee is likely to breach, Sections 4 or 5 of this
Agreement, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable
relief to restrain any such breach, without showing or proving any actual damage to the Company. Any award or relief to the Company may,
in the discretion of the court, include the Company&rsquo;s costs and expenses of enforcement (including reasonable attorneys&rsquo;
fees, court costs, and expenses). Nothing contained in this Section 6 of the Agreement or in any other provision of the Agreement shall
restrict or limit in any manner the Company&rsquo;s right to seek and obtain any form of relief, legal or equitable, and shall not waive
the Company&rsquo;s right to any other relief related to any dispute arising out of this Agreement or related to Employee&rsquo;s employment
with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>WORKS FOR HIRE</U></B>. As it is used in this Section 7 of the Agreement, the term &ldquo;Intellectual Property&rdquo; means all
discoveries, procedures, designs, creations, developments, improvements, methods, techniques, practices, methodologies, data models,
databases, scripts, know-how, processes, algorithms, application program interfaces, software programs, software source documents and
training manuals, codes, formulae, works of authorship, mask-works, reports, memoranda, ideas, inventions, customer lists, business and/or
financial information, and contributions of any kind, whether or not they are patentable, registrable, or protectable under federal or
state patent, copyright, or trade secret laws, or similar statutes, or protectable under common-law principles, and regardless of their
form or state of development, that are made, conceived, generated, or reduced to practice by Employee, in whole or in part, either alone
or jointly with others, or while Employee was serving as an officer, director, employee, or consultant of, or in any other capacity with,
the Company. Notwithstanding anything else in this Agreement, and as it used in this Section 7, the term &ldquo;Intellectual Property&rdquo;
excludes any software program, application program interface, equipment, supplies, resources, facilities, data, products, information,
materials, or trade secrets used by the Company, and which was developed entirely on Employee&rsquo;s own time, unless said Intellectual
Property: (i) relates to the Company&rsquo;s business or potential business; or (ii) results from tasks assigned to Employee by the Company
or from work performed by Employee for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property is exclusively the property of the Company. Employee will promptly disclose in writing, in full detail to persons
authorized by the Company, all Intellectual Property which Employee conceives, creates, makes, or develops during his employment with
the Company, which relate either to Employee&rsquo;s work assignment with the Company, or the trade secrets, confidential or proprietary
information, business, or potential business of the Company, for the purpose of determining the Company&rsquo;s rights in such Intellectual
Property. Employee agrees he will not file any patent application, or other application seeking intellectual property rights relating
to any such Intellectual Property without the prior written consent of the Company&rsquo;s Chief Executive Officer or his/her designee.
If Employee does not prove that Employee conceived or made the Intellectual Property entirely after leaving the Company&rsquo;s employment,
the Intellectual Property is presumed to have been conceived or made during the period of time Employee was employed by the Company,
and Employee agrees to assign said Intellectual Property to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property will belong solely to the Company from conception. The Company shall be the sole owner of all issued patents, pending
patent applications, before any relevant authority worldwide (including any additions, continuations, continuation-in-part, divisional,
reissue, reexaminations, renewals or extensions based thereon), copyrights and other works of authorship, domain names, trade secrets,
trademarks, service marks, and all other intellectual property or other rights (collectively, the &ldquo;Proprietary Rights&rdquo;) in
connection with all Intellectual Property in the United States and/or in any other country. Employee further acknowledges and agrees
that such Intellectual Property and other works of authorship shall be deemed &ldquo;works made for hire&rdquo; as defined in the U.S.
Copyright Law, 17 U.S.C. &sect; 101 et seq. (as amended), and were prepared by Employee within the scope of his employment with the Company,
for purposes of the Company&rsquo;s rights under copyright laws, and are owned by the Company. To the extent that title to any Intellectual
Property or any materials comprising or including any Intellectual Property, e.g., derivative work, including all Proprietary Rights
embodied therein, does not, by operation of law, vest in the Company, or is not considered &ldquo;works made for hire,&rdquo; Employee
hereby irrevocably assigns to the Company all of his rights, title and interest to that Intellectual Property, including all Proprietary
Rights embodied therein, free of all encumbrances and restrictions. At any time during or after Employee&rsquo;s employment with the
Company that the Company requests, Employee will cooperate, and take any action, including signing whatever written documents of assignment
the Company deems reasonably necessary, to formally evidence Employee&rsquo;s irrevocable assignment to the Company of any Intellectual
Property and all related Proprietary Rights, and, upon the Company&rsquo;s request, he shall deliver to the Company any documents which
the Company deems necessary to effect the transfer or prosecution of rights for all Intellectual Property and Proprietary Rights in the
United States and/or in any other country. At all times during and after Employee&rsquo;s employment with the Company, Employee will
cooperate and assist the Company in obtaining, maintaining and renewing patent, copyright, trademark and other appropriate protection
for any Intellectual Property, in the United States and in any other country, at the Company&rsquo;s expense. In the event that the Company
is unable, after reasonable effort, to secure Employee&rsquo;s signature on any document or documents needed to apply for or prosecute
any patent, copyright, domain name, trademark, or other right or protection relating to Intellectual Property, for any other reason whatsoever,
Employee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as his agent and attorney-in-fact,
to act for and on Employee&rsquo;s behalf to execute and file any such application or applications, and to do all other lawfully permitted
acts to further the prosecution and issuance of patents, copyrights, domain names, trademarks, or similar protections thereon with the
same legal force and effect as if executed by Employee. With respect to Intellectual Property owned by the Company, Employee hereby waives
all rights of publicity, moral rights or droit morale, and agrees not to enforce or permit others to enforce such rights against the
Company or its successors in interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
Schedule A, which is an integral part of this Agreement, Employee has completely identified (without disclosing any trade secret, proprietary
or other confidential information) Intellectual Property he conceived or made before his employment with the Company in which Employee
has an ownership interest and which is not the subject matter of an issued patent or a printed publication at the time Employee signs
this Agreement. If Employee becomes aware of any projected or actual use of any such Intellectual Property by the Company, Employee will
promptly notify the Company in writing of said use. Except as to the Intellectual Property listed on Schedule A or those which are the
subject matter of an issued patent or a printed publication at the time Employee signs this Agreement, Employee will not assert any rights
against the Company with respect to any Intellectual Property made before his employment with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Employee hereby grants to the Company a license to use, without further compensation or approval from Employee, Employee&rsquo;s
name, image, portrait, voice, likeness, and all other rights of publicity, or any derivative or modification thereto that the Company
may create, in any and all mediums, now known or hereafter developed, provided that such use is in relation to the Company&rsquo;s business
and consistent with professional business standards, and does not disparage Employee; provided, however, that if written notice is provided
to the Company by Employee following termination of Employee&rsquo;s employment (for any reason) requesting that the Company cease using
Employee&rsquo;s likeness, the Company shall have 30 calendar days to cease using Employee&rsquo;s likeness in the manner set forth in
the notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <B><U>NOTICES</U></B>.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be deemed to have been
given (i) when delivered personally or by hand (with written confirmation of receipt); (ii) if sent by a nationally-recognized
overnight courier, on the date received by the addressee (with written confirmation of receipt); or (iii) on the date sent by
electronic mail or facsimile (with confirmation of transmission), to the recipient(s) and address(es) specified below (or to such
other recipient and/or address as either Party may, from time to time, designate in writing in accordance with the terms and
conditions of this Agreement):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to Employee:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Bill White</FONT></P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0">_________________</P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0">_________________</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Company:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase Labs, Inc.</FONT></P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">711 Stewart Avenue, Suite 200</FONT></P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garden City, New York 11530</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <B><U>LEGAL
REPRESENTATION</U></B>. Employee acknowledges that he was advised to consult with, and has had ample opportunity to receive the
advice of, independent legal counsel before executing this Agreement &ndash; and the Company hereby advises Employee to do so
&ndash; and that Employee has fully exercised that opportunity to the extent he desired. Employee acknowledges that he had ample
opportunity to consider this Agreement and to receive an explanation from such legal counsel of the legal nature, effect,
ramifications, and consequences of this Agreement. Employee warrants that he has carefully read this Agreement, that he understands
completely its contents, that he understands the significance, nature, effect, and consequences of signing it, and that he has
agreed to and signed this Agreement knowingly and voluntarily of his own free will, act, and deed, and for full and sufficient
consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <B><U>ENTIRE
AGREEMENT; AMENDMENT</U></B>. This Agreement, together with the Grant Agreement and all exhibits and schedules annexed hereto,
constitutes the entire agreement between the Parties relating to the subject matter hereof, and supersedes all prior agreements and
understandings, whether oral or written, with respect to the same, including but not limited to the Company&rsquo;s offer of
employment dated April 15, 2022. In entering into and performing under this Agreement, neither the Company nor Employee has relied
upon any promises, representations, or statements except as expressly set forth herein. No modification, alteration, amendment,
revision of, or supplement to this Agreement shall be valid or effective unless the same is memorialized in a writing signed by both
by Employee and a duly-authorized representative or agent of the Company. Neither e-mail correspondence, text messages, nor any
other electronic communications constitutes a writing for purposes of this Section 10 of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <B><U>GOVERNING
LAW</U></B>. This Agreement shall in all respects be interpreted, enforced, and governed by and in accordance with the internal
substantive laws (and not the laws of choice of laws) of the State of New York. Any dispute arising out of or concerning this
Agreement, or Employee&rsquo;s employment with the Company (or separation therefrom), shall be brought in, and the parties hereby
consent to the personal jurisdiction of, any federal or state court located in New York County.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <B><U>ASSIGNMENT</U></B>.
This Agreement shall not be assignable by Employee, but shall be binding upon Employee and upon his heirs, administrators,
representatives, executors, and successors. This Agreement shall be freely assignable by the Company without restriction and,
without limitation of the foregoing, shall be deemed automatically assigned by the Company with Employee&rsquo;s consent in the
event of any sale, merger, share exchange, consolidation, or other business reorganization. This Agreement shall inure to the
benefit of the Company and its successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <B><U>SEVERABILITY</U></B>.
If one or more of the provisions of this Agreement is deemed void by law, then the remaining provisions shall continue with full
force and effect and, if legally permitted, such offending provision or provisions shall be replaced with an enforceable provision
or enforceable provisions that as nearly as possible effects the Parties&rsquo; intent. Without limiting the generality of the
foregoing, the Parties hereby expressly state their intent that, to the extent any provision of this Agreement is deemed
unenforceable due to the scope, whether geographic, temporal, or otherwise, being deemed excessive, unreasonable, and/or overbroad,
the court, person, or entity rendering such opinion regarding the scope shall modify such provision(s), or shall direct or permit
the Parties to modify such provision(s), to the minimum extent necessary to cause such provision(s) to be enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <B><U>SURVIVAL</U></B>.
Upon the termination or expiration of this Agreement, Sections 3(d) and 4 through 18 of the Agreement, together with any provisions
of the Grant Agreement that, by their terms, survive the termination or expiration of this Agreement, shall survive such termination
or expiration, and shall continue, with full force and effect, in accordance with their respective terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&nbsp; <B><U>WAIVER</U></B>.
The failure of either Party to insist, in any one or more instances, upon the performance of any of the terms, covenants, or
conditions of this Agreement or to exercise any right hereunder, shall not be construed as a waiver or relinquishment of the future
performance of any rights, and the obligations of the Party with respect to such future performance shall continue with full force
and effect. No waiver of any such right will have effect unless given in a writing signed by the Party against whom the waiver is to
be enforced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16. <B><U>COMPLIANCE
WITH SECTION 409A OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (&ldquo;SECTION 409A&rdquo;).</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
    anything herein to the contrary, to the maximum extent permitted by applicable law, amounts payable to Employee pursuant to Section
    3(b) of this Agreement shall be made in reliance upon Treas. Reg. Section 1.409A-1(b)(9) (Separation Pay Plans) or Treas. Reg. Section
    1.409A-1(b)(4) (Short-Term Deferrals), as applicable. For this purpose, each payment (including each monthly installment) shall be
    considered a separate and distinct payment, and each payment made in reliance on Treas. Reg. Section 1.409A-1(b)(9) shall only be
    payable if the Employee&rsquo;s termination of employment constitutes a &ldquo;separation from service&rdquo; within the meaning
    of Treas. Reg. Section 1.409A-1(h).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
    anything contained in this Agreement to the contrary, no amount payable on account of Employee&rsquo;s termination of employment
    which constitutes a &ldquo;deferral of compensation&rdquo; (&ldquo;Section 409A Deferred Compensation&rdquo;) within the meaning
    of the Treasury Regulations issued pursuant to Section 409A of the Code (the &ldquo;Section 409A Regulations&rdquo;) shall be paid
    unless and until Employee has incurred a &ldquo;separation from service&rdquo;, and if the 70-day payment period set forth under
    Section 3(b) of this Agreement commences in one taxable year and ends in another, then payment under such section shall not be made
    until the second taxable year. For purposes of this Agreement, &ldquo;separation from service&rdquo; shall have the meaning of such
    term as defined by the Section 409A Regulations, and each payment shall be considered a separate and distinct payment. Furthermore,
    if Employee is a &ldquo;specified employee&rdquo; within the meaning of the Section 409A Regulations as of the date of Employee&rsquo;s
    separation from service, no amount that constitutes Section 409A Deferred Compensation which is payable on account of Employee&rsquo;s
    separation from service shall be paid to Employee before the date (the &ldquo;Delayed Payment Date&rdquo;) which is first business
    day of the seventh (7th) month after the date of Employee&rsquo;s separation from service or, if earlier, the date of Employee&rsquo;s
    death following such separation from service. All such amounts that would, but for this Section, become payable prior to the Delayed
    Payment Date will be accumulated and paid on the Delayed Payment Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent that all or any portion of the Company&rsquo;s payment of benefits or reimbursements or in-kind benefits provided to Employee
    (the &ldquo;Company-Provided Benefits&rdquo;) would constitute Section 409A Deferred Compensation, then, for the duration of the
    applicable period during which the Company is required to provide such benefits: (a) the amount of Company-Provided Benefits furnished
    in any taxable year of Employee shall not affect the amount of Company-Provided Benefits furnished in any other taxable year of Employee;
    (b) any right of Employee to Company-Provided Benefits shall not be subject to liquidation or exchange for another benefit; and (c)
    any reimbursement for Company-Provided Benefits to which Employee is entitled shall be paid no later than the last day of Employee&rsquo;s
    taxable year following the taxable year in which Employee&rsquo;s expense for such Company-Provided Benefits was incurred.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company intends that income provided to Employee pursuant to this Agreement will not be subject to taxation under Section 409A of
    the Code. The provisions of this Agreement shall be interpreted and construed in favor of satisfying any applicable requirements
    of Section 409A and the Section 409A Regulations. However, the Company does not guarantee any particular tax effect for income provided
    to Employee pursuant to this Agreement. In any event, except for the Company&rsquo;s responsibility to withhold applicable income
    and employment taxes from compensation paid or provided to Employee, the Company shall not be responsible for the payment of any
    applicable taxes incurred by Employee on compensation paid or provided to Employee pursuant to this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17. <B><U>TAXES</U></B>.
The Parties acknowledge and agree that the Company may withhold from any amounts payable under this Agreement such federal, state,
local, and foreign taxes and withholdings as may be required to be withheld pursuant to any applicable law, rule, or
regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18. <B><U>SECTION
HEADINGS</U></B>. The section headings used in this Agreement are included solely for convenience, and shall not affect, or be used
in connection with, the interpretation of this Agreement. Any reference to any gender in this Agreement shall include, where
appropriate, any other gender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19. <B><U>COUNTERPARTS</U></B>.
This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original copy of this Agreement
and all of which, when taken together, will be deemed to constitute one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Parties have executed this Agreement as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYEE</B>:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
    LABS, INC.</B>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><I>/s/ Bill White</I></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    White</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
Karkus, Chief Executive Officer and</FONT></P>
                                                         <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">5/9/2022</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">5/9/2022</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTELLECTUAL
PROPERTY EMPLOYEE MADE PRIOR TO THE COMMENCEMENT OF HIS EMPLOYMENT WITH THE COMPANY, IN WHICH HE HAS AN OWNERSHIP INTEREST, WHICH ARE
NOT THE SUBJECT MATTER OF ISSUED PATENTS OR PRINTED PUBLICATIONS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(If
there are none, please enter the word &ldquo;NONE&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
Please describe each such Intellectual Property without disclosing trade secrets, proprietary or confidential information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Attach
additional sheets if more space is needed.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDUCEMENT
OPTION AWARD AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), is made effective as of the 9th day of May, 2022 (hereinafter called the &ldquo;<U>Date
of Grant</U>&rdquo;), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the &ldquo;<U>Company</U>&rdquo;), and
Bill White (hereinafter called the &ldquo;<U>Optionee</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RECITALS</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Optionee satisfies the standards for inducement grants under Nasdaq Marketplace Rule 5635(c)(4) and the related guidance under Nasdaq
IM 5635-1;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the grant of this &ldquo;Option&rdquo; (as defined below) to the Optionee was approved by the Compensation Committee of the Board of
Directors of the Company (the &ldquo;<U>Committee</U>&rdquo;) and complies with the exemption from the stockholder approval requirement
for &ldquo;inducement grants&rdquo; provided under Rule 5635(c)(4) of the Nasdaq Listing Rules;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Option evidenced by this Agreement was granted to the Optionee pursuant to the inducement grant exception under Nasdaq Stock Market
Rule 5635(c)(4), and not pursuant to any equity incentive plan of the Company, provided however, that certain terms included in the Company&rsquo;s
2022 Equity Incentive Plan (the &ldquo;2022 Plan&rdquo;) shall apply to the Option, as an inducement that is material to the Optionee
entering into employment with the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Committee has determined that it would be in the best interests of the Company and its stockholders to grant the Option provided
for herein to the Optionee pursuant to the terms set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Grant of the Option</U>. The Company hereby grants to the Optionee the right and option (the &ldquo;<U>Option</U>&rdquo;) to purchase,
on the terms and conditions hereinafter set forth, all or any part of an aggregate of 400,000 shares of common stock of the Company,
par value $0.0005 per share (the &ldquo;<U>Shares</U>&rdquo;), subject to adjustment as set forth in Section 9 of the 2022 Plan and Section
4 below. The purchase price of the Shares subject to the Option shall be $6.74 per Share (the &ldquo;<U>Option Price</U>&rdquo;).
The Option is intended to be a non-qualified stock option, and is not intended to be treated as an option that complies with Section
422 of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Vesting</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All Options granted pursuant to this Agreement shall vest and become exercisable in accordance with the following schedule, in each case,
subject to the Optionee&rsquo;s commencement of and continued Employment (as defined below) through the applicable vesting date, except
as otherwise provided in Section 2(c) below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left">Six month anniversary of Commencement Date (as defined below)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">12.5</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Twelve month anniversary of the Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Eighteen month anniversary of the Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Twenty-four month anniversary of Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Thirty month anniversary of the Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Thirty-six month anniversary of Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Forty-two month anniversary of Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Forty-eight month anniversary of Commencement Date</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.5</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="margin: 0pt 1.3in; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the foregoing vesting schedule, the number of shares vested shall be rounded down to the nearest whole share, until the last vesting date on which date the balance of the shares shall vest subject to the terms and conditions provided herein.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In the event the Optionee does not commence employment with the Company on or before May 23, 2022 (the &ldquo;Commencement Date&rdquo;),
this Option shall be automatically forfeited and cancelled for no value without any consideration being paid therefor and otherwise without
any further action of the Company whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Subject to Section 2(b), upon any termination of the Optionee&rsquo;s Employment by the Company without &ldquo;Cause&rdquo; (as defined
in the Optionee&rsquo;s employment agreement with the Company or its &ldquo;Affiliates&rdquo; (as defined below)), the Optionee shall
be credited with an additional three (3) months of vesting provided that the Optionee satisfies any terms and conditions applicable to
such additional vesting stated in the Optionee&rsquo;s employment agreement with the Company or its Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Any portion of the Option that does not become vested and exercisable in accordance with the provisions of Section 2 hereof shall be
automatically forfeited and cancelled for no value without any consideration being paid therefor and otherwise without any further action
of the Company whatsoever on the earliest to occur of the events listed in Section 3. For the avoidance of doubt, there shall be no proportionate
or partial vesting in the periods prior to each vesting date set forth in Section 2(a) and all vesting shall occur only on the applicable
vesting date, subject to the Optionee&rsquo;s commencement of and continued Employment with the Company on each applicable vesting date,
except as otherwise provided in Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Exercise of Option</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Period of Exercise</U>. Subject to the provisions of this Agreement, the Optionee may exercise all or any part of the vested portion
of the Option at any time prior to the <U>earliest</U> to occur of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the seventh anniversary of the Date of Grant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
one year following the date of the Optionee&rsquo;s termination of &ldquo;Employment&rdquo; (as defined below) due to death or &ldquo;Disability&rdquo;
(as defined below);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
one year following the date of the Optionee&rsquo;s termination of Employment by the Company without &ldquo;Cause&rdquo; (as defined
in the Optionee&rsquo;s employment agreement with the Company or its Affiliates); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the date of the Optionee&rsquo;s termination of Employment by the Company for Cause or by the Optionee for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Employment</U>&rdquo; shall mean (i) the Optionee&rsquo;s employment if the Optionee is an employee
of the Company or any of its Affiliates, (ii) the Optionee&rsquo;s services as a consultant, advisor or other service provider, if the
Optionee is a consultant, advisor or other service provider to the Company or its Affiliates and (iii) the Optionee&rsquo;s services
as a non-employee director, if the Optionee is a non-employee member of the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Disability</U>&rdquo; shall mean the inability of the Optionee to perform in all material respects
his or her duties and responsibilities to the Company or any Affiliate, by reason of a physical or mental disability or infirmity which
inability is reasonably expected to be permanent and has continued (i) for a period of six consecutive months or (ii) such shorter period
as the Committee may reasonably determine in good faith. The Disability determination shall be in the sole discretion of the Committee
and the Optionee (or his or her representative) shall furnish the Committee with medical evidence documenting the Optionee&rsquo;s disability
or infirmity which is satisfactory to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Method of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Subject to Section 3(a), the vested portion of the Option may be exercised by delivering to the Company at its principal office written
notice of intent to so exercise; <U>provided</U> that, the Option may be exercised with respect to whole Shares only. Such notice shall
specify the number of Shares for which the Option is being exercised and shall be accompanied by payment in full of the purchase price
per Share of the Option for the number of Shares for which the Option is being exercised (the &ldquo;<U>Option Price</U>&rdquo;). The
payment of the Option Price may be made at the election of the Optionee (i) in cash or its equivalent (e.g., by check), (ii) to the extent
permitted by the Committee, in Shares having a &ldquo;Fair Market Value&rdquo; (as defined below) equal to the aggregate Option Price
for the Shares being purchased and satisfying such other requirements as may be imposed by the Committee; provided, that such Shares
have been held by the Optionee for no less than six months (or such other period as established from time to time by the Committee in
order to avoid adverse accounting treatment applying generally accepted accounting principles), (iii) partly in cash and, to the extent
permitted by the Committee, partly in such Shares, (iv) if there is a public market for the Shares at such time, through the delivery
of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company
an amount out of the proceeds of such sale equal to the aggregate Option Price for the Shares being purchased, or (v) through a &ldquo;net
settlement.&rdquo; In the case of a &ldquo;net settlement&rdquo; of the Option, the Company will not require a cash payment of the Option
Price of the Option, but will reduce the number of Shares issued upon the exercise by the largest number of whole Shares that have a
Fair Market Value that does not exceed the aggregate Option Price. With respect to any remaining balance of the aggregate Option Price,
the Company shall accept a cash payment. The Optionee shall have no rights to dividends or other rights of a stockholder with respect
to Shares subject to the Option until the Optionee has given written notice of exercise of the Option, paid in full for such Shares as
applicable and, if applicable, has satisfied any other conditions set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Notwithstanding any other provision of this Agreement to the contrary, the Option may not be exercised prior to the completion of any
registration or qualification of the Option or the Shares under applicable state and federal securities or other laws, or under any ruling
or regulation of any governmental body or national securities exchange that the Committee shall in its sole discretion determine to be
necessary or advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
In the event of the Optionee&rsquo;s death, the vested portion of the Option shall remain exercisable by the Optionee&rsquo;s executor
or administrator, or the person or persons to whom the Optionee&rsquo;s rights under this Agreement shall pass by will or by the laws
of descent and distribution as the case may be, to the extent set forth in Section 3(a). Any heir or legatee of the Optionee shall take
rights herein granted subject to the terms and conditions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Fair Market Value</U>&rdquo; shall mean on a given date, (i) if there should be a public market
for the Shares on such date, the closing price of the Shares as reported on such date on the composite tape of the principal national
securities exchange on which such Shares are listed or admitted to trading or, if no composite tape exists for such national securities
exchange on such date, then the closing price on the principal national securities exchange on which such Shares are listed or admitted
to trading, (ii) if the Shares are not listed or admitted on a national securities exchange, the arithmetic mean of the per Share closing
bid price and per Share closing asked price on such date as quoted on the National Association of Securities Dealers Automated Quotation
System (or such other market in which such prices for the Shares are regularly quoted) or (iii) if there is no market on which the Shares
are regularly quoted, the Fair Market Value shall be the value established by the Committee in good faith and in accordance with Section
409A of the Internal Revenue Code of 1986, as amended; provided, however that in determining the Fair Market value, the Committee shall
not apply a discount for any minority interest. With respect to (i) and (ii) above, if no sale of Shares shall have been reported on
such composite tape or such national securities exchange on such date or quoted on the National Association of Securities Dealer Automated
Quotation System or other applicable market on such date, then the immediately preceding date on which sales of the Shares have been
so reported or quoted shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Adjustments Upon Certain Events</U>. Notwithstanding any other provisions of this Agreement to the contrary, the following provisions
shall apply to the Option granted under this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Generally</U>. The Option shall be subject to the adjustment provisions of Section 9 of the 2022 Plan, as if granted thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Change of Control</U>. The Option shall be subject to the change of control provisions of Section 9 of the 2022 Plan, as if granted
thereunder. For purposes of this Agreement, &ldquo;Change of Control&rdquo; shall be as defined in the 2022 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Option Recovery</U>. If the Committee determines that the Optionee (a) engaged in conduct that constituted Cause as defined in the
Optionee&rsquo;s employment agreement with the Company or its Affiliates at any prior to the Optionee&rsquo;s termination of services,
(b) engaged in conduct during the 6 month period after the Optionee&rsquo;s termination of services that would have constituted Cause
if the Optionee had not ceased to provide services, or (c) violates the terms of any non-compete agreement, non-solicitation agreement,
confidentiality agreement, or any other restriction on the Optionee&rsquo;s post-termination activities established under any agreement
with the Company or other Company policy or arrangement during the 6 months after the Optionee&rsquo;s ceases to provide services to
the Company, then (i) any Option held by the Optionee shall immediately terminate, and the Optionee shall automatically forfeit all Shares
underlying any exercised portion of an Option for which the Company has not yet delivered the Share certificates, upon refund by the
Company of the Option Price paid by the Optionee for such Shares and (ii) the Optionee shall return any Shares received upon exercise
of this Option or repay to the Company any proceeds received from the sale of other disposition of the Shares transferred pursuant to
this Option less the Option Price. Upon any exercise of an Option, the Company may withhold delivery of share certificates pending resolution
of an inquiry that could lead to a finding resulting in a forfeiture under this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>No Right to Continued Employment</U>. The granting of the Option evidenced hereby and this Agreement shall impose no obligation on
the Company or any Affiliate to continue the Employment of the Optionee and shall not lessen or affect the Company&rsquo;s or its Affiliate&rsquo;s
right to terminate the Employment of such Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Transferability</U>. The Option may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by
the Optionee otherwise than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge,
attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate; provided that the designation
of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. No such permitted
transfer of the Option to heirs or legatees of the Optionee shall be effective to bind the Company unless the Committee shall have been
furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the
transfer and the acceptance by the transferee or transferees of the terms and conditions hereof. During the Optionee&rsquo;s lifetime,
the Option is exercisable only by the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Withholding</U>. The Optionee may be required to pay to the Company or any Affiliate and the Company shall have the right and is hereby
authorized to withhold, any applicable withholding taxes in respect of the Option, its exercise or any payment or transfer under or with
respect to the Option and to take such other action as may be necessary in the opinion of the Committee to satisfy all obligations for
the payment of such withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Securities Laws</U>. Upon the acquisition of any Shares pursuant to the exercise of the Option, the Optionee will make or enter into
such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities
laws or with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Notices</U>. Any notice necessary under this Agreement shall be addressed to the Company in care of its Secretary at the principal
executive office of the Company and to the Optionee at the address appearing in the personnel records of the Company for the Optionee
or to either party at such other address as either party hereto may hereafter designate in writing to the other. Any such notice shall
be deemed effective upon receipt thereof by the addressee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Choice of Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware without
regard to conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Section 409A</U>. The Company intends that income realized by the Optionee pursuant to this Agreement will not be subject to taxation
under Section 409A of the Code. The provisions of this Agreement shall be interpreted and construed in favor of satisfying any applicable
requirements of Section 409A of the Code. In the event that it is reasonably determined by the Committee that, as a result of Section
409A of the Code, any payment or delivery of Shares in respect of the Option may not be made at the time contemplated by the terms of
this Agreement, as the case may be, without causing Optionee to be subject to taxation under Section 409A of the Code, the Company shall
use reasonably commercial efforts to make such payment or delivery of Shares on the first day that would not result in the Optionee incurring
any tax liability under Section 409A of the Code. If Optionee is a &ldquo;specified employee&rdquo; (within the meaning of Section 409A(a)(2)(B)(i)
of the Code), any payment and/or delivery of Shares in respect of the Option that are linked to the date of the Optionee&rsquo;s separation
from service shall not be made prior to the date which is six (6) months after the date of such Optionee&rsquo;s separation from service
from the Company, determined in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company, in
its reasonable discretion, may amend (including retroactively) this Agreement in order to conform to the applicable requirements of Section
409A of the Code, including amendments to facilitate the Optionee&rsquo;s ability to avoid taxation under Section 409A of the Code. However,
the preceding provisions shall not be construed as a guarantee by the Company of any particular tax result for income realized by the
Optionee pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Administration</U>. This Agreement shall be administered by the Committee. The Committee is authorized to interpret this Agreement,
to establish, amend and rescind any rules and regulations relating to this Agreement, and to make any other determinations that it deems
necessary or advisable for the administration of this Agreement. The Committee may correct any defect or supply any omission or reconcile
any inconsistency in this Agreement in the manner and to the extent the Committee deems necessary or advisable. Any decision of the Committee
in the interpretation and administration of this Agreement, as described herein, shall lie within its sole and absolute discretion and
shall be final, conclusive and binding on all parties concerned (including, but not limited to, the Optionee and his or her beneficiaries
or successors). The Committee shall have the full power and authority to establish the terms and conditions of this Option consistent
with the provisions of this Agreement and to waive any such terms and conditions at any time (including, without limitation, accelerating
or waiving any vesting conditions). Awards may, in the discretion of the Committee, be granted in assumption of, or in substitution for,
any outstanding portion of this Option. The Committee shall require payment of any minimum amount it may determine to be necessary to
withhold for federal, state, local or other, taxes as a result of the exercise, vesting or grant of this Option. Unless the Committee
specifies otherwise, the Optionee may elect to pay a portion or all of such withholding taxes by (a) delivery in Shares or (b) having
Shares withheld by the Company from any Shares that would have otherwise been received by the Optionee. The number of Shares so delivered
or withheld shall have an aggregate Fair Market Value sufficient to satisfy the applicable minimum withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Successors and Assigns</U>. This Agreement shall be binding on all successors and assigns of the Company and the Optionee, including,
without limitation, the estate of the Optionee and the executor, administrator or trustee of such estate, and any receiver or trustee
in bankruptcy or any other representative of the Optionee&rsquo;s creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Signature in Counterparts</U>. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect
as if the signatures thereto and hereto were upon the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signatures
on next page.</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PROPHASE
    LABS, INC</B>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 45%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OPTIONEE</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill White</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    White</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
Page to Inducement Option Award Agreement]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><IMG SRC="ex99-1_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs Announces Appointment of Bill White as Chief Financial Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garden
City, NY &ndash; May 10, 2022 (GLOBE NEWSWIRE) &ndash; ProPhase Labs, Inc. <FONT STYLE="background-color: white">(Nasdaq: PRPH), a diversified
diagnostics and genomics company, announced today </FONT>that Bill White has been appointed Chief Financial Officer (CFO) of ProPhase
Labs, effective May 23, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
White joins ProPhase Labs from Intellicheck, Inc., where he served as Chief Financial Officer, Treasurer and Secretary since April 2012
and Chief Operating Officer since March 2020. Mr. White has more than 30 years of experience in financial management, operations and
business development. Prior to joining Intellicheck, he served 11 years as the Chief Financial Officer, Secretary and Treasurer of FocusMicro,
Inc. (&ldquo;FM&rdquo;). As co-founder of FM, Mr. White played an integral role in growing the business from the company&rsquo;s inception
to over $36 million in annual revenue in a five-year period. Mr. White has broad domestic and international experience including managing
rapid and significant growth, import/export, implementing tough cost management initiatives, exploiting new growth opportunities, merger
and acquisitions, strategic planning, resource allocation, tax compliance and organization development. Prior to co-founding FM, he served
15 years in various financial leadership positions in the government sector. Mr. White started his career in Public Accounting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
are thrilled to have Bill join our executive team,&rdquo; said Ted Karkus, Chief Executive Officer of ProPhase. &ldquo;Bill&rsquo;s financial
expertise will be an important addition to our company as we work to grow our business strategy and valuation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
am very pleased to have the opportunity to work with Ted and the ProPhase team,&rdquo; said Mr. White. &ldquo;I look forward to providing
my finance expertise and supporting the Company&rsquo;s goals and upcoming milestones.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
White will succeed Monica Brady, who has served as ProPhase Labs&rsquo; CFO since January 2019. Ms. Brady will remain at ProPhase Labs
and will report to Mr. White in her continuing role as Chief Accounting Officer of ProPhase Labs and Chief Financial Officer of ProPhase
Diagnostics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
want to thank Monica for her work as CFO over the past several years and dedication to our company as we drove the acceleration of our
new business model,&rdquo; said Mr. Karkus. &ldquo;We are grateful for her many contributions during this time of rapid change.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inducement
Award</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
White was awarded a stock option to purchase up to 400,000 shares of ProPhase common stock as an inducement to his employment as Chief
Financial Officer of ProPhase Labs. This award was made in accordance with the employment inducement award exemption provided by Nasdaq
Rule 5635(c)(4) and was therefore not awarded under the Company&rsquo;s stockholder approved equity plan. The option award will vest
over a four year period, with 12.5% vesting every six months following the date his employment commences, contingent upon the commencement
of his employment and continued service through each vesting date. The options have an exercise price of $6.74 per share and will be
exercisable for a period of seven years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
ProPhase Labs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs, Inc. (Nasdaq: PRPH) (&ldquo;ProPhase&rdquo;) is <FONT STYLE="background-color: white">a diversified diagnostics and genomics company</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ProPhase
Diagnostics, Inc., a wholly-owned subsidiary of ProPhase, offers a broad array of clinical diagnostic and testing services at its CLIA
certified laboratories including state-of-the-art polymerase chain reaction (PCR) testing for SARS-CoV-2 (COVID-19). Critical to COVID-19
testing, ProPhase Diagnostics provides fast turnaround times for results. ProPhase Diagnostics also offers best-in-class rapid antigen
and antibody/immunity tests to broaden its COVID-19 testing beyond RT-PCR testing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Precision Medicine, Inc., a wholly-owned subsidiary of ProPhase, focuses on genomics testing technologies, a comprehensive method for
analyzing entire genomes, including the genes and chromosomes in DNA. The data obtained from genomic testing can help to identify inherited
disorders and tendencies, help predict disease risk, help identify expected drug response, and characterize genetic mutations, including
those that drive cancer progression.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Global Healthcare, Inc., a subsidiary of ProPhase, was formed to seek to expand the Company&rsquo;s SARS-CoV-2 (COVID-19) testing into
other countries and to pursue additional healthcare-related initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
has decades of experience researching, developing, manufacturing, distributing, marketing, and selling OTC consumer healthcare products
and dietary supplements under the TK Supplements<SUP>&reg;</SUP> brand and Phamaloz contract manufacturing subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
actively pursues strategic investments and acquisition opportunities for other companies, technologies, and products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, visit <U>www.ProPhaseLabs.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Relations and Institutional Investor Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">267-880-1111</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>investorrelations@prophaselabs.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Retail
Investor Relations Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renmark
Financial Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
Boidman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">514-939-3989</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jboidman@renmarkfinancial.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# -$# 2(  A$! Q$!_\0
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>prph-20220509.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamE6bP9z5Z8GekhvWB1bbm6DyEv1qQcnyI3CxTmoXcB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:PRPH="http://prophaselabs.com/20220509" elementFormDefault="qualified" targetNamespace="http://prophaselabs.com/20220509">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://prophaselabs.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="prph-20220509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="prph-20220509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>prph-20220509_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>prph-20220509_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://prophaselabs.com/role/Cover" xlink:href="prph-20220509.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://prophaselabs.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140356102788776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PROPHASE
LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000868278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-2577138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">711
    Stewart Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">G<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">arden
    City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-0919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRPH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prph-20220509.xsd" xlink:type="simple"/>
    <context id="From2022-05-09to2022-05-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-05-09</startDate>
            <endDate>2022-05-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-05-09to2022-05-09">0000868278</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-05-09to2022-05-09">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-05-09to2022-05-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-05-09to2022-05-09">2022-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-05-09to2022-05-09">PROPHASE LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-05-09to2022-05-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-05-09to2022-05-09">000-21617</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-05-09to2022-05-09">23-2577138</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-05-09to2022-05-09">711     Stewart Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-05-09to2022-05-09">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2022-05-09to2022-05-09">G</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2022-05-09to2022-05-09">arden     City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-05-09to2022-05-09">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-05-09to2022-05-09">11530</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-05-09to2022-05-09">(215)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-05-09to2022-05-09">345-0919</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-05-09to2022-05-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-05-09to2022-05-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-05-09to2022-05-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-05-09to2022-05-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-05-09to2022-05-09">Common     Stock, par value $0.0005</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-09to2022-05-09">PRPH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-09to2022-05-09">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-05-09to2022-05-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MS>[E?G=B=9*_4"^TA=?S_' M."P#=P-\O]3:OI^X=_3B)Y;AOU!+ P04
M" # 2JI4GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"
M/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[
M1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK
M6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)
ML;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP
M::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2
MVSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=
M5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>6
M5Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEU
MXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z
M6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//
M\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#
M$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_N
MG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=
MXI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%
M^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_
M5U/\!%!+ P04    " # 2JI4EXJ[',     3 @  "P   %]R96QS+RYR96QS
MG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2
MW!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N
M&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HC
ME5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,E
MC'%BM/XU@LD/['X 4$L#!!0    ( ,!*JE2JQ"(6,P$  "("   /    >&PO
M=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'
MA8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>
MBD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#
M.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'
MV#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T
M/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6= ;N\N@#FW+()FKJ
MIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ
M_)[E#U!+ P04    " # 2JI4)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N
M"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7
MK.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*
M%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)
MKM\,<'AT_@%02P,$%     @ P$JJ5&60>9(9 0  SP,  !,   !;0V]N=&5N
M=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2
MVS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\
MFK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9
MHS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM
M0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-
M"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&
M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " # 2JI4!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( ,!*JE3F-LZ3[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,!*JE297)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MP$JJ5%Q_K8M=!   ;A$  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,!*JE2?H!OPL0(  .(,   -
M          "  : ,  !X;"]S='EL97,N>&UL4$L! A0#%     @ P$JJ5)>*
MNQS     $P(   L              ( !? \  %]R96QS+RYR96QS4$L! A0#
M%     @ P$JJ5*K$(A8S 0  (@(   \              ( !91   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,!*JE0D'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( ,!*JE1ED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex99-1.htm</File>
    <File>prph-20220509.xsd</File>
    <File>prph-20220509_lab.xml</File>
    <File>prph-20220509_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prph-20220509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prph-20220509_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prph-20220509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "PRPH",
   "nsuri": "http://prophaselabs.com/20220509",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-05-09to2022-05-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://prophaselabs.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-05-09to2022-05-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-22-012630-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-012630-xbrl.zip
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MJ+I6\?1=^6UU;DD%2\J>Q!CSB7Y2A38K([)*/<EP_" F\81(";^X.2BOHZ1
M018MZXE.GF3X1*2WMQ6\ T%[\7>Q*H&\USF1O."=FF6&;F'"QRPGW7MBD.20
M,W^U$0!:[7N;I[!>S'J@=4TR&H:M6MNTR5=)"4\ \6F2-T+LRSRK/<?5:V<G
ML)\^$_L<E:93^BVQ3Q;KG13Q;M(#RLQZ.&<4Q/[[2?FE5SLV*O6^D!'\>1!=
M$$-O648R./Y.LFA:P58RK8K7B+EZ6X'@^;F4,I:ZY<),DFDR":)Y7G.6XM1*
MMTOG\_!_WDPK-I+*9F+K22ASFF0SK\[2-.GQOM5%?\SA7")9N]MYE4TYL(I
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MJMW2S^<,5U(1.Z!#'9-A3T]MS5:=UFF4I%A!6E7!"%"X2J=2"PQH<KZ<,25
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MCXS$,BW!M!4K<AJ)2:2K$J>)I]IDT?[UDP3*)@#"6EJE' TMI;.#UQ5OBY:
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MN[U/F5:SS7,A@I/FL5?ACVE:OUK+U$5VO 2?0VM+VS<BC[Y&2B6 6J6U%9R
M-)(8Q2Z'*G0=Y8+&><V=FEC#%LMS"6=@*2=*8G+LA2PK=Y]HZ*E ]_@!9$Z
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M$7-',5GG4>$\E_(E';'?(-77S;",;'%;)5<#9-> _I,KN *I@1"!0Q#=5V?
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M]Q6+@5%#Z13U(3A%L!6[:990>);]@ 5'4]:2*+ ^_I:B$DE!+:\&]7Y7G&(
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MKD1DA.-FSJP$Y)#0C%0 06>G7J/W89C+3!CN9#JI$!5:GW,330DR[1:#[$O
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MC^K 57=PU>SI7YL[;+-W^>OI<;.SN]5B/2/]HH%(1_FX7BLZ-A;,8LE()1U
M :4= 9>;E'L+^Q6V];.!\.3*V=;] W!E=6F\$:9J8N44*6XM*T_/G)S0G05_
MA(4?(QW/MV62%)NSZ&))8&]V5#1OPT+X2NF1F&MT'PR;L$7Y]#D.GSPW]XT
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M*O)2J#P#\,D!R/WU2S4ODH==NJPD4]HE"3"X<ZEI]>Z3IYYE3J)LYDOH'4Z
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MY?Y2M$U_/![^FIS^Z/R_4$L#!!0    ( ,!*JE0UJ3;[Q!H  +G)   +
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M*&\JF^AKKU^J_+%:75,-0;UHZ__ZVB3MBF@(Z]5%+GB-#"(O0#X:%>*#MMZ
M@\&H$')Z^.8LY9"#NPW.)8FYVQK22:&8K;Q1!1'6P9L$F'7Y@*CW6(%RC.Z*
M05;@&ZXFU2,\[>"F8UF/-C[QG6 VCA^(0/E,*E@L66+JK(R!L9I4?CBC1@=\
MU8!"I" ^7!=G)#5K@RBDP4$K(&+4,\Y?6]GM,@Y7JX963\,"QU9=?1.4^IZR
M3#HJ>ICAW!/TJB!7S6+A<BBT[&*XH_WM%>8M#N:-O283I8_>PRC_E3 'IG&1
M/,*L2$OBP.!&#LV42Q7Y3C6<_I3[&-M%I P^J5-P=$6P10E=)X K#!%]*[(@
MDU&,.24Z.K3)<8I-3S@=:>55F"8/H_/ 64<'5"?P1P>.--JNKRFX3<_P5/?(
M!M\,_!3EBP7^,32 LTC@B*?QO7TXOB:,VK<=RLU8AC'N^2E "9,7=5WI1C49
MN?O:(]W@T*_K-Q^@^0D?,Y*'HA'42OFDL4"CI5@'L:T;.*+*%>$@<]I&S\8;
MG\20VQ->]0;=Q Q3"(NA!-2H@WSR!$/X%,J-JP@ZI1)!2$?L2("P@WP(9@0P
MOQ8$'@E96:R+)XD22"T4GR+RF=2-HWX289%'.AYI94GC5RU%FTD:'XUD.!X@
M$'1^T0L&0T?]&+>-Z>Z5I:21:1/MQ SL*9N=-*LH6!2VI:MIU5U?T[J[0OM%
M0?M]B.*-1PB5 >=P@5W(/8S_\<6;M^B%@?(H-XSHYA$F=*JWPQV( )G79V ]
M,7<5HS,[,DL1+'EJ%([67EN3@&)JGX\$G:E><(\3A']#O96*JBR,&^R;&G48
M!7KZU:?*S]"8C6O X/N6@RU1UZSM:]K)3>9TI8%_>&U^)YLOD$L%+W5\=>T?
M6!5?<K%,:%JQC+N1GK#G^:^-%_+AXGA\9N!X<-U$1Q]O@(X<BV ]/)PSZ?B>
MBAB")*\!XRK"C"@;5W(@(G$BU!GOF"-.8;<M;NGEP/J@PYO<([N[V8)V+J!,
M+?  @C<L TQ$=XZJC)\;>X<6)O(!KKB:%2%4A<\0O?W>'>4KH'D>T.PBT(QT
M1KT:0+OV*-9 %5;H\R?)WS A>@@EL3KH/]'[ZSWHOUV:[RVU%V($P7,Y) Y%
M?_=5O_-D\PN;[1%S#<F=L1=D+M@A[P4]3[J@9*UNQIK;2 OY;&&E*K_BOU'2
MD7A,CPT*^4PAV_&Z>'@P*?=L*H=<YT_'MNPV]6IQF*5(VL&+ST=;<0]R=&%?
MV;.@BK"@9*V@;)Y05ERIRMR@K*BAK#%:*8\OXT_CVJ\A6G8%::^%K!6DS6VD
MF/A;J<I\(&UW-_3.KE3:]3I(NX[0*TP3KZ#HM9"U@J(Y>E?EE:;\ JTUW+ZG
MR5/'J_%4D:31A@M*CKG%R ;K-IF)NPAQ^3C8!-VP+6XS\OG=]1DQA>&K346O
M^UZJI^\^**WN/EC=?;!,=Q_\P,)H2/!K6)J=VJ I<:^SC*X<>,X%:>-K]GB>
MT/2M(3%P.Y>I5\3UCAI<(&\R=4A0;\OC'BZH=ZC5"O:$K:^I#3=!"5P8]_&8
MDVJ/^EY'2*#=?+'5\=7"WO)Y/4]Y&#!P_/EMJOC#/)WS!H(PO:)I&^58%OO-
M[H%:5=1U5XOI$X87O2\\A>7M%R9QD51G084Q3[+>#<,72<0<F!=<@Y\K(/'#
MG)O3Q,8O;L$W4J]4:D76Q%TH2D,T*8&:K%1D1=98ZD3?Z8243.VI76G+BJQE
M\EU>?K,;]=A>,/F.K6DLO)@6E*S_M>1J>3]8Z'?W()1TO56N]2=RK4MUFVIR
M,BG7%.80E3W7\;K6X;C2W#!OG^ ;-?;(P!SLD\:1^G"?WWEWKZX6=]61?C5J
M58]]&!P_W.5/^P_5OSMWN;\O^X,OQ\5\[<S_=B,>/[EWXFNC6*S9]6[_VY?K
M#SG&KWOT4_^Z4S[NL,O=[=MRYY_*V=^#L]M3XV/A[MWU?[YM?;3]>JWC/7KO
MC/.'[G#[9OC>J'W-G3"S^>GA/SM7WVKM_LF'A^/;FC [%^^WSJO;\OC#V?'5
ML7UI_=UP[K:Z[5*C)[X6S<>3PN7#[ATMB9/\Q8>/5U?O9*G[SYTH;W7,+UN"
M#K;$K7MT\7A7J0V_5(Z8^'#YM[EU>M(:'!GOK[^<?#A]5[;K#_9MKY7[5/I0
MM(^\?SSSZ_NS6];)B?[.I]JC=:+9\?]02P,$%     @ P$JJ5#*N^&(] P
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M*=T:,4%$;%.O[9X[3R;?7 H:!)P]GD#1:%,$7RGG'X1<B@DE6@J:E.E :);
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M+D8  (OH 0 *              "  0    !E>#$P+3$N:'1M4$L! A0#%
M  @ P$JJ5*!?N?BR(   RM<   H              ( !5D8  &5X,3 M,BYH
M=&U02P$"% ,4    " # 2JI44S6T'@<,  ![/@  "@              @ $P
M9P  97@Y.2TQ+FAT;5!+ 0(4 Q0    ( ,!*JE0UJ3;[Q!H  +G)   +
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3!@     '  < I@$  '2D      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
